OR WAIT null SECS
September 16, 2022
Life sciences companies are collaborating more with technology enterprises, universities, and other groups, which is changing the landscape of the industry.
September 08, 2022
Barnes discusses alternative reimbursement plans for expensive, one-off therapies.
August 17, 2022
Environmental, social, and governance (ESG) standards are becoming more important for modern investors.
July 27, 2022
Corrigan discusses the importance of a patient-centric approach.
July 15, 2022
Patients with Crohn's disease and ulcerative colitis face a high disease burden.
July 08, 2022
With heightened government scrutiny on educational forums, biopharma manufacturers need a sound framework that demonstrates they are following best practices.
A proactive and tailored compliance department—with the nimbleness to adapt strategies on the fly—is a critical shield for life sciences companies during government investigations.
June 29, 2022
As director of corporate strategy for Novartis, Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.
Employees must be able to retain information and remain engaged to keep pace with highly regulated industry.
June 17, 2022
We may be only at the beginning of outcome-measured, value-based healthcare, but this is a chance for pharma organizations to show their mettle as roles are redefined and definitions of ‘value’ are agreed, says Gérard Klop of Vintura.
